Checkpoint Inhibitor Immune-Related Adverse Events: A Multimodality Pictorial Review-Reference-Cited by-同舟云学术

Checkpoint Inhibitor Immune-Related Adverse Events: A Multimodality Pictorial Review

Published:2022-12 Issue:12 Volume:29 Page:1869-1884
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Capaccione Kathleen M.^ORCID,Valiplackal Jacienta P.,Huang Alice,Roa Tina,Fruauff Alana,Liou Connie,Kim Eleanor,Khurana Sakshi,Maher Mary,Ma Hong,Ngyuen Pamela,Mak Serena,Dumeer Shifali,Lala Sonali,D'souza Belinda,Laifer-Narin Sherelle,Desperito Elise,Ruzal-Shapiro Carrie,Salvatore Mary M.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference122 articles.

1. Challenges in assessing solid tumor responses to immunotherapy;Chai;Cancer Gene Therapy,2020

2. Anti-PD-1 and Anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations;Seidel;Front Oncol,2018

3. Checkpoint inhibitors: What gastroenterologists need to know;Ahmed;World J Gastroenterol,2018

4. Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway;Wu;Acta Pharmacologica Sinica,2021

5. Preserving the CTLA-4 checkpoint for safer and more effective cancer immunotherapy;Liu;Trends Pharmacolog Sci,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Machine Learning–Based Model Using CT Radiomics for Predicting Immune Checkpoint Inhibitor-related Pneumonitis in Patients With NSCLC Receiving Anti-PD1 Immunotherapy: A Multicenter Retrospective Case Control Study;Academic Radiology;2023-11

2. Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer;Cancers;2023-05-21

3. Intra-Abdominal Malignant Melanoma: Challenging Aspects of Epidemiology, Clinical and Paraclinical Diagnosis and Optimal Treatment—A Literature Review;Diagnostics;2022-08-24